ArticleJournal of clinical microbiology2019
Reply from Kirn and Sharp to Brecher, 'EUCAST and CLSI Point-Counterpoint on Susceptibility Breakpoints: Do Two "I Agree"s Miss the Point?'
Thomas J Kirn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.